Glenmark’s Ryaltris nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age
Mumbai, 26 April 2021: Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, is concluding the final, national phase of...
